The Cooper Companies, Inc. (COO) Stock Price, News, Quote & History
This article provides detailed financial information for The Cooper Companies, Inc. (COO), including its current stock price, recent performance metrics, and key financial ratios. It covers the company's business segments—CooperVision and CooperSurgical—and offers analyst insights, earnings trends, and a performance comparison against the S&P 500. The data presented reflects activity up to September 25, 2026.
Cooper Companies (COO) Opens Vision Centre To Speed New Contact Lens Development
Cooper Companies (COO) has launched "The Vision Centre," a new global hub dedicated to accelerating contact lens product development for its CooperVision division. This center unifies research, pilot manufacturing, and clinical expertise, aiming to streamline the development of future contact lens products. The initiative supports Cooper Companies' strategy to focus on premium and specialty lenses and addresses previous product transition challenges, highlighting the importance for investors to monitor upcoming product pipeline updates.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
Pomerantz LLP is investigating potential securities fraud claims against The Cooper Companies, Inc. (NASDAQ: COO) following a significant drop in its stock price. The investigation began after Cooper announced Q3 2026 results with flat year-over-year revenue and lowered full-year guidance due to U.S. channel inventory reductions, causing its stock to fall by 14.67%. Investors affected by this decline are encouraged to contact the law firm.
Cooper Companies faces securities fraud probe a...
Pomerantz LLP is investigating The Cooper Companies for potential securities fraud after the company announced flat Q3 2026 revenue and lowered full-year guidance, leading to a nearly 15% stock drop. The investigation will determine if unlawful business practices occurred, and investors are encouraged to contact the firm regarding a class action lawsuit. This comes as the broader US health sector saw 67 out of 100 priced stocks fall, with notable movers including Ascendis Pharma A/S, Revvity Inc, and BioNano Genomics Inc.
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
The Cooper Companies (COO) announced the opening of The Vision Centre, a new global innovation hub in Southampton, England, for its CooperVision business, focused on accelerating contact lens development and commercialization. The company also unveiled six product advancements, with launches planned over the next several years, aiming to drive future growth through enhanced innovation capabilities. Following the news, COO stock gained 1.4% at yesterday's close, despite a year-to-date decline, as these strategic investments are expected to strengthen its product portfolio and market position.
ICU Medical, Inc. (ICUI) Stock forecasts
Argus has issued a stock forecast for ICU Medical, Inc. (ICUI), raising its target price to $169.00 from a current price of $166.02. The report, dated September 23, 2026, describes ICU Medical as a California-based pure-play infusion therapy company.
CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal?
CooperCompanies (COO) has decided to retain its CooperSurgical unit after a strategic review, concluding that offers received were not in shareholders' best interest. The company also expanded its share repurchase program from $2 billion to $3 billion, signaling confidence in its fundamentals. Despite some Q3 weaknesses like lower gross margins and flat organic growth in CooperVision, the company plans operational improvements and accelerated product launches.
Cooper Companies Opens New Global Innovation Hub
Cooper Companies has launched "The Vision Centre" in Southampton, England, an innovation hub designed to integrate research, clinical expertise, and commercial capabilities for new product development. The company plans to introduce six major product advancements, including one-day contact lenses for myopia control, and will leverage digital tools and AI for product development. Despite recent stock fluctuations and analyst downgrades following a Q3 earnings miss and inventory issues, the company maintains a stable market performance and commitment to technological investment.
COOPER COMPANIES, INC. COO INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 14.7% Share Drop
Kirby McInerney LLP is investigating Cooper Companies, Inc. (NASDAQ: COO) following a 14.7% share drop after the company announced third-quarter 2026 financial results that fell short of analyst expectations. The revenue miss was attributed to the performance of its CooperVision segment, which saw flat year-over-year revenue due to proactive reduction of U.S. channel inventory. The law firm is encouraging investors who purchased CooperCompanies securities to contact them to discuss potential claims under federal securities laws.
The world's first full family of daily contacts to manage nearsightedness is planned, with five other advances.
CooperCompanies announced the opening of CooperVision's global innovation hub, The Vision Centre, in Southampton, England. This new facility will accelerate the launch of six major contact lens advancements over the next several years, including the world's first complete family of daily contact lenses for myopia control, premium and entry-level daily silicone hydrogel lenses, and new toric and multifocal toric designs. These innovations represent a significant investment in research and development aimed at addressing evolving vision care needs and driving future growth for CooperVision.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
Rosen Law Firm has initiated an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following allegations of materially misleading business information provided to investors. This action comes after CooperCompanies' stock dropped 14.6% on September 10, 2026, due to a disappointing earnings report and the decision not to sell CooperSurgical, prompting the firm to prepare a class action lawsuit to recover investor losses. Investors who purchased CooperCompanies securities are encouraged to contact Rosen Law Firm to join the prospective class action without upfront fees.
The Cooper Companies, Inc. (COO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Cooper Companies, Inc. (COO) following a significant drop in its stock price. This drop occurred after the company announced flat third-quarter 2026 revenues and lowered its full-year guidance due to U.S. channel inventory reductions. Shareholders are encouraged to contact the firm to learn more about participating in the investigation.
The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS
Hagens Berman has opened an investigation into The Cooper Companies (NASDAQ: COO) after its stock dropped sharply following revelations of U.S. channel inventory destocking and other negative surprises in its Q3 2026 financial results. The firm is scrutinizing whether Cooper was sufficiently transparent about its sales practices, particularly concerning its CooperVision segment, and if securities laws were violated. Investors who suffered substantial losses are encouraged to come forward.
Bronstein, Gewirtz & Grossman, LLC Is Investigating The Cooper Companies, Inc. (COO) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against The Cooper Companies, Inc. (COO) after the company announced its Q3 2026 results, which included flat revenue, channel inventory reductions impacting future quarters, and lowered full-year guidance. Following this news, Cooper Companies' stock price dropped significantly. The firm is encouraging investors who purchased Cooper Companies securities to assist in the investigation.
'Investor trust has been broken': Activist pushes Cooper Cos. to divest products, ditch CEO
Activist investor Jana Partners is pressuring Cooper Cos. to divest certain products and replace its CEO. This marks the second time in the past year that the company has faced public pressure from an activist shareholder. The article highlights investor dissatisfaction and the push for significant corporate changes.
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
The Rosen Law Firm has announced an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following a significant stock drop. This investigation comes after a Motley Fool article highlighted weak guidance and a decision not to sell CooperSurgical, causing CooperCompanies' stock to fall by 14.6% on September 10, 2026. The firm is preparing a class action lawsuit to recover investor losses and encourages affected shareholders to join the prospective action.
Cooper Companies continues to see activist pressure to sell divisions, replace CEO
Activist investor Jana Partners is intensifying its pressure on Cooper Companies, calling for the sale of its divisions and the replacement of its CEO following a lowered financial guidance for 2026. The firm criticized Cooper's "problematic forecasting" and "poor capital allocation" after the company decided against selling its CooperSurgical division and reported flat growth in its CooperVision segment. Jana Partners also seeks an external search for a new chief executive and board chair, alongside the appointment of new directors.
Activist investor urges Cooper Companies to replace CEO, sell some assets
Activist investor Jana Partners is pressuring Cooper Companies to replace its CEO and sell off certain assets, including its fertility and medical device segments, due to "chronic underperformance." This demand comes after Cooper Companies lowered its earnings and revenue forecasts and decided against selling CooperSurgical following a strategic review. Jana Partners also suggested evaluating the sale of the CooperVision segment and implementing revised compensation metrics for better accountability.
A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain?
The Cooper Companies (COO) abandoned the sale of its CooperSurgical unit after nine months, as bids did not align with shareholder interests, leading to a 15% stock drop to a 52-week low. The core issue is identified as flat organic revenue growth in its CooperVision contact lens business, alongside a channel inventory reduction and lowered guidance. While the company's free cash flow is strong and there's a share buyback program, the stock's future hinges on the reacceleration of CooperVision's growth and resolution of surgical pressures.
Bronstein, Gewirtz & Grossman, LLC Encourages The Cooper Companies, Inc. (COO) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Cooper Companies, Inc. (COO) following a significant drop in its stock price. This drop occurred after the company announced flat third-quarter 2026 revenue, attributed to channel inventory reductions, and subsequently lowered its full-year guidance for both revenue and EPS. The law firm is encouraging affected investors to inquire about their investigation.
How Is Cooper Companies' Stock Performance Compared to Other Medical Instruments & Supplies Stocks?
Cooper Companies (COO) has underperformed in the medical instruments and supplies sector, with its stock declining significantly from its 52-week high and lagging behind the MDEV ETF. The decline is attributed to weaker-than-expected Q3 2026 revenue, primarily due to weak contact lens demand and reduced U.S. channel inventory, leading analysts to maintain a "Hold" rating on the stock.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against The Cooper Companies, Inc. (COO) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into The Cooper Companies, Inc. (COO) following a significant drop in stock price after the company reported disappointing Q3 2026 results and lowered its full-year guidance. The firm is encouraging investors who purchased Cooper Companies securities to learn more about the potential claims related to the reported revenue decline and reduced earnings per share guidance.
‘Crisis of Its Own Creation’: Activist JANA Blasts Cooper, Demands CEO Search
Activist investor Jana Partners has sharply criticized The Cooper Companies (NASDAQ: COO) for persistent financial underperformance, poor forecasting, and eroding shareholder confidence. The firm is demanding immediate leadership changes, including an external search for a new CEO and a new board chair, along with strategic operational overhauls. Jana Partners also suggested evaluating asset sales and hiring a performance consultant to improve cost efficiencies.
Cooper Companies (COO) Securities Investigation Notice - Levi & Korsinsky
Levi & Korsinsky is investigating Cooper Companies (COO) after the company's stock fell nearly 15% following a revenue shortfall and reduced guidance. The company disclosed that it "proactively reduced U.S. channel inventory" in its CooperVision segment, impacting Q4 results and guidance. The investigation focuses on whether investors were adequately informed about demand trends, inventory levels, and the growth outlook for CooperVision.
Exclusive | Jana Partners Pushes Contact-Lens Maker Cooper to Replace Its CEO
Activist hedge fund Jana Partners is pressuring contact-lens manufacturer Cooper Cos. to replace its CEO and consider divesting its core businesses. The firm sent a letter to Cooper on Thursday, advocating for an urgent overhaul due to what it calls "chronic underperformance."
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against The Cooper Companies, Inc. (COO) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into The Cooper Companies, Inc. (COO) following a significant drop in its stock price. This comes after Cooper Companies announced its third-quarter 2026 results, reporting flat revenue year-over-year and lowering its full-year guidance due to U.S. channel inventory reductions, leading to a 14.67% stock decline. The firm is encouraging investors who purchased Cooper Companies securities to join the investigation into potential claims.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against The Cooper Companies, Inc. (COO) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against The Cooper Companies, Inc. (COO) following a significant drop in its stock price. This decline occurred after the company announced flat year-over-year revenue in Q3 2026 and lowered its full-year guidance due to U.S. channel inventory reductions. The firm encourages stockholders affected by these events to assist in the investigation.
Insider Rosebrough Walter M Jr Acquires 10,000 Shares of COOPER COMPANIES (NASDAQ: COO) at $54.11-$54.29
Insider Rosebrough Walter M Jr purchased 10,000 shares of COOPER COMPANIES (NASDAQ: COO) across two transactions on September 11 and September 14, at prices ranging from $54.11 to $54.29 per share. These open-market purchases, reported under SEC transaction code P, increase his total holdings in the company to 20,000 shares.
COOPERCOMPANIES ALERT: Bragar Eagel & Squire, P.C. is Investigating The Cooper Companies, Inc. on Behalf of CooperCompanies Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against The Cooper Companies, Inc. (NASDAQ:COO) on behalf of its stockholders. This investigation follows CooperCompanies' announcement of third-quarter 2026 financial results, which fell short of analyst expectations, causing its stock price to decline by approximately 14.7%. The law firm encourages investors who suffered losses to contact them to discuss their legal rights.
Mlazgar Appeals Hubbell Lighting Verdict. Both Demand Millions in Fees.
Mlazgar Associates has appealed the August verdict in its case against Hubbell Lighting, where Hubbell won a significant breach of contract counterclaim. Following the verdict, both companies are now demanding millions in attorneys' fees, with Mlazgar seeking $3.84 million and Hubbell Lighting asking for $2.69 million. The appeal process is expected to be lengthy, and Mlazgar also faces an upcoming trial against Focal Point and Legrand for separate commission claims, adding to its financial challenges.
Cooper Companies Insider Bought Shares Worth $539,150, According to a Recent SEC Filing
An insider at Cooper Companies (COO) recently purchased shares valued at $539,150, as detailed in a recent SEC filing. This transaction was published on September 15, 2026, at 05:00 pm EDT, according to MT Newswires. The article highlights recent news concerning Cooper Companies, including other insider transactions and analyst rating adjustments.
COOPER COMPANIES, INC. INVESTIGATION: COO Securities
Kirby McInerney LLP is investigating potential claims against The Cooper Companies, Inc. (NASDAQ: COO) after its third-quarter 2026 financial results fell short of analyst expectations. The company reported $1.07 billion in revenue, $30 million less than anticipated, largely due to reduced U.S. channel inventory in its CooperVision segment. This news led to a 14.7% drop in CooperCompanies' share price.
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
Rosen Law Firm has announced an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO). This follows allegations that CooperCompanies may have issued misleading business information, leading to a 14.6% stock drop on September 10, 2026, after weak guidance and a decision not to sell CooperSurgical disappointed Wall Street. The firm is preparing a class action lawsuit to recover investor losses.
The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand
The Cooper Companies (COO) has cut its fiscal 2026 profit and revenue forecasts due to weaker-than-expected demand for contact lenses, primarily impacting its CooperVision business. Despite this, the company saw adjusted third-quarter EPS increase and free cash flow jump, and has maintained its long-term free cash flow objective. The decision to retain CooperSurgical, instead of selling it, has also been a point of contention for investors.
The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S.
The Cooper Companies (NASDAQ: COO) is under scrutiny by Hagens Berman after its stock dropped significantly due to revelations of U.S. channel inventory reductions in its CooperVision segment. The firm is investigating whether the company was transparent about its sales practices leading up to the Q3 2026 financial results, which caused a substantial loss in market capitalization. Investors who suffered losses are encouraged to contact Hagens Berman for a potential securities law violation investigation.
Bronstein, Gewirtz & Grossman, LLC Is Investigating The Cooper Companies, Inc. (COO) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against The Cooper Companies, Inc. (COO) following a significant drop in its stock price. This investigation comes after the company announced flat third-quarter revenue, reported U.S. channel inventory reductions, and subsequently lowered its full-year guidance, causing its stock to fall by over 14%. The law firm is encouraging affected investors to connect with them for more information regarding potential class action claims.
Cooper Companies Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cooper Companies (COO)
Levi & Korsinsky, LLP has announced an investigation into Cooper Companies (NASDAQ: COO) after the company slashed its fiscal 2026 growth projections for CooperVision for the second time, leading to a nearly 15% stock drop. The investigation focuses on whether Cooper Companies made misleading statements regarding CooperVision's organic growth outlook and U.S. channel inventory conditions. Shareholders who experienced losses are encouraged to contact the firm for a review of their legal rights.
Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision
Cooper Companies (COO) reported Q3 fiscal 2026 results, showing a 1% increase in topline revenue and a 4% jump in adjusted diluted EPS. The company saw strong growth in its fertility segment within CooperSurgical and record free cash flow, which helped offset weakness in the CooperVision segment due to soft demand in Asia Pacific and the Americas. Despite lowering its full-year guidance, Cooper reiterated its long-term free cash flow target, emphasizing strategic priorities for profitable expansion and shareholder value.
Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision
The Cooper Companies (COO) announced strong Q3 FY26 results, with topline growth and adjusted EPS exceeding projections, driven by its fertility segment and robust free cash flow. Despite weakness in the CooperVision segment due to soft sales in Asia Pacific and Americas, the company strengthened its strategic position through share repurchases and a raised buyback authorization. However, management lowered its full-year guidance for FY26, projecting lower organic growth and adjusted diluted EPS, while reiterating a long-term free cash flow target.
Wells Fargo cuts Cooper Companies stock price target on guidance miss
Wells Fargo has lowered its price target for Cooper Companies (NASDAQ:COO) stock from $66 to $61, maintaining an Equal Weight rating. This adjustment follows the company's decision not to sell its CooperSurgical division and its issuance of lower fiscal year 2026 guidance. Other analysts from Piper Sandler, Baird, and BofA Securities also downgraded the stock due to mixed Q3 2026 results and the decision to retain CooperSurgical.
Cooper Companies Stock Crashed 15% on Thursday. The Guidance Cut Wasn’t the Whole Story.
Cooper Companies (COO) stock dropped 15% after cutting its FY2026 EPS guidance and abandoning the sale of CooperSurgical. While the guidance cut was attributed to a temporary inventory adjustment in CooperVision and the scrapped sale disappointed investors, the company reported record free cash flow and a raised buyback authorization. Analysts' mean target suggests a significant upside, and TIKR's model values the stock higher, indicating it might be a recovery play rather than a broken business.
Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In T
Limoneira Company (NASDAQ: LMNR) reported worse-than-expected Q3 financial results, with earnings of 2 cents per share against an estimated 19 cents, and sales of $43.809 million missing the $49.618 million consensus. This led to an 8.4% drop in its shares in pre-market trading. Other companies also saw their stock prices fall, including The Cooper Companies, Inc. (NASDAQ: COO) due to mixed results and cut guidance, and Navan, Inc. (NASDAQ: NAVN) despite raising its full-year outlook.
Intel, Cooper Companies among market cap stock movers on Thursday
Thursday's market saw significant stock movements, with Intel (INTC) and Cooper Companies (COO) highlighted as major movers. Intel's stock fell after Piper Sandler initiated coverage with a "Neutral" rating due to valuation, while Cooper Companies experienced a drop following a downgrade from Baird citing weak sales. The article details other significant stock movements across mega-cap, large-cap, mid-cap, and small-cap categories.
AeroVironment pops after earnings, and other early market movers
AeroVironment (AVAV) shares surged 6% in premarket trading after exceeding analyst expectations for its fiscal first-quarter 2027 revenue and earnings. Conversely, Cooper Cos. (COO) saw a more than 15% drop after lowering its earnings outlook, while American Eagle Outfitters (AEO) fell 11% despite beating profit and revenue estimates, due to missing comparable-store sales forecasts. Navan (NVN) also experienced a 14% decline despite narrowing its Q2 loss and acquiring an AI platform, after raising its full-year outlook.
Cooper Companies Slides After Q3 2026; Stock Drops 17%
Cooper Companies (NASDAQ: COO) reported Q3 2026 non-GAAP diluted EPS of $1.15, beating estimates, and revenue of $1.07B, meeting expectations. Despite the modest earnings beat, the stock dropped 17.1% due to flat performance in its CooperVision segment and cautious guidance for Q4 2026, signaling investor concerns about future growth. The MiSight myopia management franchise showed strong growth, but it was not enough to offset the overall stagnation in the core contact lens business.
Cooper Companies Releases Q3 2026 Financial Results
The Cooper Companies, Inc. (COO) reported its Q3 2026 financial results, exceeding analyst expectations for non-GAAP diluted EPS at $1.15 versus $1.11, a 3.6% beat. Revenue reached $1.07 billion, aligning with estimates, though the CooperVision segment saw flat revenue year-over-year. The company provided Q4 2026 guidance and faces a mixed analyst outlook with 7 buy and 10 hold ratings.
These Analysts Slash Their Forecasts On Cooper Companies Following Q3 Results
Cooper Companies (NASDAQ: COO) reported mixed Q3 financial results, beating earnings estimates but missing sales forecasts, and subsequently lowered its FY26 guidance. Following this announcement, several analysts downgraded the stock and reduced their price targets, leading to a significant dip in Cooper Companies' shares during pre-market trading. The company's CEO noted that while earnings exceeded expectations and fertility growth was solid, reduced U.S. channel inventory at CooperVision negatively impacted results.
VEON Ltd (VEON) Reiterated at Buy by StoneX- Being Recognised as Premier TMT Company
StoneX analyst Matt Harrigan reiterated a Buy rating and an $85.00 price target for VEON Ltd (NASDAQ: VEON), citing its position as a premier TMT company and national champion in Central Asian and Ukrainian markets. The analyst highlighted the success of Pakistan’s JazzCash, satellite integration in Ukraine, and potential sovereign AI monetization across VEON's 65M+ super-app users. Harrigan suggests VEON could re-rate from a frontier market telecom to a comprehensive vertical digital app leader, with a fair value assessment potentially increasing to over $125 under a sum-of-the-parts valuation.
Stifel Adjusts Price Target on Cooper Companies to $70 From $85, Keeps Buy Rating
Stifel has adjusted its price target for Cooper Companies (COO) to $70, down from $85, while maintaining a Buy rating on the stock. This adjustment comes amidst a series of analyst rating changes and price target revisions for Cooper Companies, following what appears to be disappointing fiscal Q3 sales and a cut in full-year guidance. Several other firms, including Citigroup, BofA Securities, Piper Sandler, Needham, Wells Fargo, JPMorgan, Jefferies, and Baird, have also revised their ratings and price targets for the company.
Baird Downgrades Cooper Companies to Neutral From Outperform, Adjusts Price Target to $61 From $85
Baird has downgraded Cooper Companies (COO) from Outperform to Neutral, lowering its price target to $61 from $85. This comes after Cooper Companies recently cut its annual profit forecast due to weaker-than-expected contact lens demand. The company also reported Q3 adjusted earnings and revenue increases, but provided Q4 guidance that suggested caution.
